For over 25 years, we have been recruiting patients to study risk factors and predictors of cardiometabolic and other diseasesProspective patient studiesRead more
Large biobanks and own molecular laboratory for analysis and validation of new biomarkersBiomarker discoveryRead more
Working with cell lines to investigate the molecular mechanisms underlying obesity-related and other diseasesBasic researchRead more
Our efforts have generated extensive databases that form the foundation for advanced statistical analysesAdvanced data analyticsRead more

VIVIT – Vorarlberg Institute for Vascular Investigation and Treatment

The Vorarlberg Institute for Vascular Investigation and Treatment, in short VIVIT, is a scientific institute primarily dedicated to the research and treatment of metabolic and cardiovascular diseases such as diabetes and arteriosclerosis. Additionally, VIVIT places a significant focus on the study of kidney and cancer diseases.

The VIVIT’s team comprises around 20 life sciences specialists with a background in medicine and natural sciences who joined forces to tackle questions in diabetology, lipidology, cardiology, nephrology, oncology, and molecular biology in an interdisciplinary fashion.

The team authored more than 500 publications in scientific journals and covered a broad range of topics from basic research all the way to clinical applications.

Facts and Figures

25 Staff
25 Years of Expertise
500 Published Papers
3,000 Academic Study Patients

Key Research Areas

Cardiovascular

VIVIT investigates cardiovascular risk factors and their role in newly emerging cardiovascular complications.

Diabetes & Metabolism

Our research examines the origins of type 2 diabetes and other metabolic disorders, while also evaluating their impact on the prognosis of patients at cardiovascular risk.

Cancer

VIVIT’s cancer research focuses on identifying biomarkers that can influence the therapeutic response and progression of cancer.

Kidney

Our scientific focus is on the outcomes of patients undergoing kidney replacement therapies.

Key research activities

Prospective patient studies

For over 25 years, we have been recruiting patients to study risk factors and predictors of cardiometabolic and other diseases.

Biomarker discovery

VIVIT’s large biobanks and own molecular laboratory facilitate analysis and validation of new biomarkers.

Basic research

We cultivate adipocytes and other cell lines to investigate the molecular mechanisms underlying obesity-related and other diseases.

AI & Advanced data analytics

Our efforts have generated extensive databases that form the foundation for ongoing statistical analyses.

© Copyright - Vivit 2025